Journals' conflict of interest policy
Revised International Committee of Medical Journal Editors' conflict of interest policy, to be published in 10 journals the week of Sept. 10, urges increased author independence and accountability for publications (1"The Pink Sheet" Aug. 20, p. 8)
You may also be interested in...
Pharmacia is preparing to publish the full 12-month data from the Celebrex CLASS GI outcomes study.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials